Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Michelle F. Cronk"'
Autor:
Peter Grimison, J. Shannon, Siobhan Ng, Paul Vasey, Niall C. Tebbutt, Katrin Marie Sjoquist, John Zalcberg, L. L. Lipton, Michelle F. Cronk, Danielle Ferraro, Sue-Anne McLachlan, Christos S. Karapetis, Christine Aiken, Val Gebski, Rachel O'Connell, David Goldstein
Publikováno v:
Cancer chemotherapy and pharmacology. 78(2)
The phase II TACTIC trial prospectively selected patients with KRAS wild-type advanced biliary tract cancer for first-line treatment with panitumumab and combination chemotherapy.Of 78 patients screened, 85 % had KRAS wild-type tumours and 48 were en
Autor:
Val Gebski, Rachel O'Connell, Lara Lipton, Suresh C Varma, Paul Vasey, David Goldstein, J. Shannon, Sue-Anne McLachlan, Chris Karapetis, E Abdi, Michael Jefford, Nicole Wong, Peter Grimison, John Zalcberg, Eva Segelov, Sarah Chinchen, Niall C. Tebbutt, Katrin Marie Sjoquist, Michelle F. Cronk, Siobhan Ng
Publikováno v:
Annals of Oncology. 25:iv244
Aim: Curative surgery is possible in less than a third of patients with biliary tract carcinoma (BTC). Most patients die of progressive cancer. This trial was designed to combine an optimal schedule of gemcitabine and cisplatin with the EGFR antibody
Autor:
Louise M. Nott, Katrin Marie Sjoquist, Thomas Van Hagen, Michelle F. Cronk, Merryn Hall, Stephen Begbie, Danielle Ferraro, Christos S. Karapetis, John R. Mackey, David Goldstein, Val Gebski, Rachel O'Connell, Cheryl Santos, E Abdi, Nicole Wong, Yu Jo Chua, Craig Underhill
Publikováno v:
Journal of Clinical Oncology. 32:228-228
228 Background: GEM-based treatment is a standard treatment for metastatic pancreas cancer. Monotherapy efficacy is only modest, and outcomes are improved by combination treatment or the non-GEM FOLFIRINOX triplet. There is a need for biomarkers to s
Autor:
Lara Lipton, Christopher J. O'Callaghan, Louise M. Nott, Timothy J. Price, Yoon-Koo Kang, Yung-Jue Bang, Jenny Shannon, Niall C. Tebbutt, Margot J. Burnell, D. Harris, Thierry Alcindor, Eric Tsobanis, Andrew Strickland, David Goldstein, Sonia Yip, Nick Pavlakis, Katrin Marie Sjoquist, Michelle F. Cronk, Andrew J. Martin, Matthew Burge
Publikováno v:
Journal of Clinical Oncology. 31:TPS4157-TPS4157
TPS4157 Background: Advanced Oesophago-Gastric Carcinoma (AOGC) has a poor prognosis, and there is no established standard treatment following failure of first or second line chemotherapy (CT). Regorafenib (BAY 73-4506)(REG) is an oral multi-kinase i
Autor:
John Simes, Dongsheng Tu, Asif Shaikh, Lillian L. Siu, David Wyld, Warren Joubert, O'Callaghan. Christopher J., Malcolm J. Moore, Ian Walters, Craig Underhill, Penny Phillips, Benoit Samson, Timothy J. Price, Michelle F. Cronk, Antonino Bonaventura, Brian Peter Findlay, Jeremy Shapiro, Catherine Doyle, Derek J. Jonker, John Zalcberg
Publikováno v:
Journal of Clinical Oncology. 30:3572-3572
3572 Notice of Retraction: "Analysis of plasma biomarkers potentially associated with antiangiogenic resistance in NCIC CTG/AGITG CO.20: A phase III randomized trial of cetuximab (CET) plus either brivanib alaninate (BRIV) or placebo in patients (pts
Autor:
David Goldstein, Katrin Marie Sjoquist, Val Gebski, Michelle F. Cronk, Nicole Wong, Christos S. Karapetis, Yu Jo Chua, Craig Underhill, Andrew V. Biankin, Louise M. Nott
Publikováno v:
Web of Science
TPS4137 Background: Biomarker-based selection of cancer treatments has already entered routine clinical practice in some cancer types. Recent retrospective data suggests the human equilibrative nucleoside transporter 1 (hENT1) to be promising predict